Browsing by Author Marre, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2005ADVANCE - Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline.Adams, Mark; Chalmers, John; Cooper, Michael; Fulcher, Greg; MacMahon, Stephen; Mitchell, Ronald (Paul); Neal, Bruce; Patel, Anushka; Pollock, Carol; Watson, John; Woodward, Mark; et, al; Ferrannini, E; Glasziou, Paul P; Grobbee, Diederick E.; Hamet, P; Harrap, S; Heller, S; Liu, L; Mancia, Giuseppe; Marre, M; Central Clinical School: Medicine; The George Institute for International Health; Central Clinical School: Obstetrics & Gynaecology; Northern Clinical School: Medicine; The George Institute for International Health; Western Clinical School: Westmead Millennium Institute; The George Institute for International Health; The George Institute for International Health; Northern Clinical School: Medicine; School of Medical Sciences: Biomedical Sciences; The George Institute for International HealthADVANCE - Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline., Diabetic Medicine: 2005 Diabetes UK, vol.22,(7),2005,pp 882-888
2017PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation studyChalmers, John; Woodward, Mark; Haloui, Mounsif; Hamet, Pavel; Harrap, S; Harvey, Francois; Kanzki, B; Long, Carole; Marois-Blanchet, Francois-Christophe; Marre, M; Raelson, John; Simon, Paul H G; Sylvestre, Marie-Pierre; Tahir, Muhammad-Ramzan; Tremblay, Johanne; The George Institute for Global Health; The George Institute for Global HealthPROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study, Journal of Hypertension, vol.35, Suppl 1, 2017,pp S24-S32